Cormorant Global Healthcare GP, LLC
Insider CIK 1618451 · PTI 10% owner · APLS 10% owner · AXNX 10% owner · KZR 10% owner · KNSA 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| AXNX Axonics Modulation Technol | C Conversion deriv | 2018-10-31 | 2018-11-02 | 599,999 | — | $0 | 0 | SEC↗ |
| AXNX Axonics Modulation Technol | C Conversion deriv | 2018-10-31 | 2018-11-02 | 552,495 | — | $0 | 0 | SEC↗ |
| AXNX Axonics Modulation Technol | C Conversion | 2018-10-31 | 2018-11-02 | 552,495 | — | $0 | 1,152,494 | SEC↗ |
| AXNX Axonics Modulation Technol | P Buy | 2018-10-31 | 2018-11-02 | 133,333 | $15.00 | $2.00M | 1,285,827 | SEC↗ |
| AXNX Axonics Modulation Technol | C Conversion | 2018-10-31 | 2018-11-02 | 599,999 | — | $0 | 599,999 | SEC↗ |
| KZR Kezar Life Sciences, Inc. | C Conversion deriv | 2018-06-25 | 2018-06-27 | 315,488 | — | $0 | 0 | SEC↗ |
| KZR Kezar Life Sciences, Inc. | C Conversion deriv | 2018-06-25 | 2018-06-27 | 1,007,421 | — | $0 | 0 | SEC↗ |
| KZR Kezar Life Sciences, Inc. | C Conversion | 2018-06-25 | 2018-06-27 | 315,488 | — | $0 | 315,488 | SEC↗ |
| KZR Kezar Life Sciences, Inc. | P Buy | 2018-06-25 | 2018-06-27 | 250,000 | $15.00 | $3.75M | 1,572,909 | SEC↗ |
| KZR Kezar Life Sciences, Inc. | C Conversion | 2018-06-25 | 2018-06-27 | 1,007,421 | — | $0 | 1,322,909 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | C Conversion deriv | 2018-05-29 | 2018-05-31 | 830,999 | — | $0 | 0 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | C Conversion | 2018-05-29 | 2018-05-31 | 830,999 | — | $0 | 830,999 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | P Buy | 2018-05-29 | 2018-05-31 | 69,444 | $18.00 | $1.25M | 900,443 | SEC↗ |
| PTI PROTEOSTASIS THERAPEUTICS, | S Sale | 2017-12-14 | 2017-12-18 | 504,027 | $4.88 | $2.46M | 3,300,000 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | C Conversion deriv | 2017-11-13 | 2017-11-14 | 2,098,581 | — | $0 | 0 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | C Conversion deriv | 2017-11-13 | 2017-11-14 | 303,916 | — | $0 | 0 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | P Buy | 2017-11-13 | 2017-11-14 | 1,071,428 | $14.00 | $15.00M | 3,473,925 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | C Conversion | 2017-11-13 | 2017-11-14 | 2,402,497 | — | $0 | 2,402,497 | SEC↗ |
| PTI PROTEOSTASIS THERAPEUTICS, | P Buy | 2016-12-13 | 2016-12-14 | 21,301 | $10.98 | $233.9K | 3,804,027 | SEC↗ |
| PTI PROTEOSTASIS THERAPEUTICS, | P Buy | 2016-12-12 | 2016-12-14 | 100,000 | $10.79 | $1.08M | 3,782,726 | SEC↗ |
| PTI PROTEOSTASIS THERAPEUTICS, | P Buy | 2016-12-08 | 2016-12-09 | 21,819 | $10.93 | $238.5K | 3,682,726 | SEC↗ |
| PTI PROTEOSTASIS THERAPEUTICS, | P Buy | 2016-12-07 | 2016-12-09 | 22,598 | $10.74 | $242.7K | 3,660,907 | SEC↗ |
| PTI PROTEOSTASIS THERAPEUTICS, | P Buy | 2016-12-06 | 2016-12-06 | 8,216 | $10.89 | $89.5K | 3,638,309 | SEC↗ |
| PTI PROTEOSTASIS THERAPEUTICS, | P Buy | 2016-12-05 | 2016-12-06 | 29,757 | $10.78 | $320.8K | 3,630,093 | SEC↗ |
| PTI PROTEOSTASIS THERAPEUTICS, | P Buy | 2016-12-02 | 2016-12-06 | 50,000 | $10.48 | $524.0K | 3,600,336 | SEC↗ |
| PTI PROTEOSTASIS THERAPEUTICS, | P Buy | 2016-12-01 | 2016-12-01 | 41,984 | $10.11 | $424.5K | 3,550,336 | SEC↗ |
| PTI PROTEOSTASIS THERAPEUTICS, | P Buy | 2016-11-29 | 2016-12-01 | 128,407 | $10.28 | $1.32M | 3,508,352 | SEC↗ |
| PTI PROTEOSTASIS THERAPEUTICS, | P Buy | 2016-11-23 | 2016-11-23 | 180,300 | $11.37 | $2.05M | 3,379,745 | SEC↗ |
| PTI PROTEOSTASIS THERAPEUTICS, | P Buy | 2016-11-23 | 2016-11-23 | 200 | $10.67 | $2.1K | 3,379,945 | SEC↗ |
| PTI PROTEOSTASIS THERAPEUTICS, | P Buy | 2016-11-22 | 2016-11-23 | 69,500 | $11.08 | $770.1K | 3,199,445 | SEC↗ |
| PTI PROTEOSTASIS THERAPEUTICS, | P Buy | 2016-11-21 | 2016-11-23 | 111,863 | $11.64 | $1.30M | 3,129,945 | SEC↗ |
| PTI PROTEOSTASIS THERAPEUTICS, | P Buy | 2016-11-14 | 2016-11-14 | 9,500 | $11.48 | $109.1K | 3,018,082 | SEC↗ |
| PTI PROTEOSTASIS THERAPEUTICS, | P Buy | 2016-11-11 | 2016-11-14 | 21,200 | $11.46 | $243.0K | 3,008,582 | SEC↗ |
| PTI PROTEOSTASIS THERAPEUTICS, | P Buy | 2016-11-10 | 2016-11-14 | 216,700 | $11.07 | $2.40M | 2,987,382 | SEC↗ |
| PTI PROTEOSTASIS THERAPEUTICS, | P Buy | 2016-11-09 | 2016-11-14 | 12,100 | $9.68 | $117.1K | 2,770,682 | SEC↗ |
| PTI PROTEOSTASIS THERAPEUTICS, | P Buy | 2016-11-07 | 2016-11-07 | 231,700 | $8.69 | $2.01M | 2,758,582 | SEC↗ |
| PTI PROTEOSTASIS THERAPEUTICS, | P Buy | 2016-11-04 | 2016-11-07 | 2,597 | $7.27 | $18.9K | 2,453,497 | SEC↗ |
| PTI PROTEOSTASIS THERAPEUTICS, | P Buy | 2016-11-04 | 2016-11-07 | 73,403 | $8.09 | $593.8K | 2,526,882 | SEC↗ |
| PTI PROTEOSTASIS THERAPEUTICS, | P Buy | 2016-11-03 | 2016-11-07 | 20,277 | $7.24 | $146.8K | 2,450,882 | SEC↗ |